BREANA SCHROEDER: Open Payments
NPI 1912789678 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,445 in 144 payments from 21 companies in 2025. Trend: 2023 $61 · 2024 $1,375 · 2025 $2,445
Food & beverage: $2,445
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $516 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $304 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $303 |
| Lucid Diagnostics Inc. | 17 | $281 |
| Phathom Pharmaceuticals, Inc. | 7 | $132 |
| QOL Medical, LLC | 6 | $124 |
| Ardelyx, Inc. | 6 | $123 |
| Ipsen Biopharmaceuticals, Inc | 5 | $99 |
| Organon LLC | 4 | $84 |
| Lilly USA, LLC | 4 | $81 |
Products named: XIFAXAN, SKYRIZI, ENTYVIO, RINVOQ, VOQUEZNA, Sucraid, IBSRELA, EOHILIA.
Industry payments across OH — which companies pay providers there.
